Close Window

Digital Look Email A Friend

Gilead raises 2020 forecasts after Covid-19 surge boosts remdesivir

Published by Abigail Townsend on 11th January 2021

(Sharecast News) - Gilead Sciences has upped its full-year profit guidance following strong sales of its Covid-19 treatment remdesivir.

URL: http://www.digitallook.com/dl/news/story/31564620/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.